<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
EXAS
Exact Sciences
$
()


  • Exact Sciences CFO's resume 'impressive,' says William Blair

    4/15/2024 - 10:21am
  • Exact Sciences names Aaron Bloomer as CFO, effective May 15

    4/15/2024 - 06:02am
  • Exact Sciences to supply individual cancer information to Mayo Clinic patients

    4/4/2024 - 06:09am
  • Exact Sciences removed from 'Tactical Outperform' list at Evercore ISI

    4/3/2024 - 08:21am
  • Citi opens 'positive catalyst watch' on Exact Sciences after competitor data

    4/3/2024 - 06:03am
  • Canaccord positive on Exact, Guardant after Freenome data

    4/3/2024 - 05:19am
  • Exact Sciences, Guardant rally after Freenome colorectal cancer test results

    4/2/2024 - 09:49am
  • Unusually active option classes on open April 2nd

    4/2/2024 - 09:41am
  • Exact Sciences' Oncoguard Esophagus test shows efficacy in published study

    3/28/2024 - 06:09am
  • EXACT Sciences call volume above normal and directionally bullish

    3/21/2024 - 11:06am
  • Exact Sciences added to 'Tactical Outperform' list at Evercore ISI

    3/19/2024 - 08:31am
  • Exact Sciences says Cologuard Plus test results published in NEJM

    3/13/2024 - 17:04pm
  • Exact Sciences price target lowered by $10 at Canaccord, here's why

    2/22/2024 - 07:32am
  • Exact Sciences price target lowered by $5 at BTIG, here's why

    2/22/2024 - 07:25am
  • Exact Sciences sees FY24 revenue $2.81B-$2.85B, consensus $2.83B

    2/21/2024 - 16:14pm
dynamic_feed Breaking News